UBS AM’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$48.1M Buy
850,819
+212,094
+33% +$12.4M 0.01% 635
2025
Q4
$38M Sell
638,725
-435,448
-41% -$23.7M 0.01% 675
2025
Q3
$58.2M Sell
1,074,173
-245,619
-19% -$14M 0.01% 579
2025
Q2
$72.5M Buy
1,319,792
+254,868
+24% +$15M 0.01% 604
2025
Q1
$75.3M Buy
1,064,924
+9,837
+0.9% +$662K 0.02% 600
2024
Q4
$69.4M Buy
1,055,087
+174,634
+20% +$11.7M 0.02% 595
2024
Q3
$61.9M Sell
880,453
-132,587
-13% -$11.1M 0.02% 629
2024
Q2
$83.4M Buy
1,013,040
+268,239
+36% +$22.3M 0.02% 498
2024
Q1
$65.1M Sell
744,801
-1,839
-0.2% -$165K 0.02% 544
2023
Q4
$72M Sell
746,640
-9,696
-1% -$858K 0.03% 507
2023
Q3
$66.9M Sell
756,336
-100,693
-12% -$8.96M 0.03% 501
2023
Q2
$83.3M Hold
857,029
0.04% 434
2023
Q1
$83.3M Sell
857,029
-156,532
-15% -$16.2M 0.04% 434
2022
Q4
$105M Sell
1,013,561
-260,605
-20% -$24.5M 0.06% 369
2022
Q3
$108M Sell
1,274,166
-288,199
-18% -$25.7M 0.06% 351
2022
Q2
$129M Buy
1,562,365
+10,748
+0.7% +$856K 0.07% 311
2022
Q1
$120M Buy
1,551,617
+419,371
+37% +$35.1M 0.05% 378
2021
Q4
$100M Buy
1,132,246
+45,170
+4% +$3.73M 0.04% 462
2021
Q3
$84M Sell
1,087,076
-954,407
-47% -$75.3M 0.03% 487
2021
Q2
$170M Sell
2,041,483
-196,578
-9% -$15.6M 0.07% 292
2021
Q1
$169M Sell
2,238,061
-224,204
-9% -$18.3M 0.07% 281
2020
Q4
$216M Buy
2,462,265
+444,701
+22% +$35.3M 0.1% 207
2020
Q3
$153M Buy
2,017,564
+848,740
+73% +$85.9M 0.08% 236
2020
Q2
$144M Sell
1,168,824
-137,364
-11% -$13.7M 0.09% 227
2020
Q1
$110M Sell
1,306,188
-40,972
-3% -$3.53M 0.08% 247
2019
Q4
$114M Buy
1,347,160
+194,514
+17% +$14.7M 0.07% 298
2019
Q3
$77.7M Buy
1,152,646
+137,044
+13% +$10.6M 0.05% 374
2019
Q2
$87M Sell
1,015,602
-152,762
-13% -$13.1M 0.06% 339
2019
Q1
$104M Sell
1,168,364
-15,858
-1% -$1.47M 0.08% 280
2018
Q4
$101M Buy
1,184,222
+64,718
+6% +$6.16M 0.09% 254
2018
Q3
$109M Sell
1,119,504
-58,085
-5% -$5.8M 0.08% 272
2018
Q2
$111M Buy
1,177,589
+28,971
+3% +$2.54M 0.09% 269
2018
Q1
$93.1M Buy
1,148,618
+10,276
+0.9% +$882K 0.07% 301
2017
Q4
$102M Buy
1,138,342
+79,591
+8% +$6.92M 0.09% 266
2017
Q3
$98.5M Sell
1,058,751
-12,488
-1% -$1.1M 0.09% 251
2017
Q2
$97.3M Sell
1,071,239
-16,756
-2% -$1.52M 0.09% 251
2017
Q1
$95.5M Buy
1,087,995
+110,504
+11% +$9.83M 0.1% 230
2016
Q4
$81M Sell
977,491
-103,601
-10% -$8.91M 0.09% 244
2016
Q3
$100M Sell
1,081,092
-18,369
-2% -$1.73M 0.11% 218
2016
Q2
$85.5M Sell
1,099,461
-48,178
-4% -$4.1M 0.1% 233
2016
Q1
$94.7M Buy
1,147,639
+96,052
+9% +$7.82M 0.11% 206
2015
Q4
$110M Sell
1,051,587
-32,399
-3% -$3.38M 0.13% 183
2015
Q3
$114M Sell
1,083,986
-34,773
-3% -$4.64M 0.13% 183
2015
Q2
$153M Sell
1,118,759
-166,660
-13% -$20.7M 0.15% 154
2015
Q1
$160M Buy
1,285,419
+139,945
+12% +$14.8M 0.15% 153
2014
Q4
$104M Sell
1,145,474
-553
-0% -$46K 0.1% 233
2014
Q3
$82.7M Buy
1,146,027
+24,253
+2% +$1.59M 0.08% 267
2014
Q2
$69.8M Buy
1,121,774
+9,881
+0.9% +$597K 0.07% 302
2014
Q1
$75.8M Buy
1,111,893
+270,465
+32% +$19.9M 0.08% 276
2013
Q4
$59.1M Sell
841,428
-67,517
-7% -$4.59M 0.07% 319
2013
Q3
$65.6M Buy
908,945
+58,274
+7% +$3.87M 0.08% 274
2013
Q2
$47.5M Buy
+850,671
New +$53M 0.06% 326

Other funds holding BMRN